Condition

Low-risk Myelodysplastic Syndromes clinical trials and research

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• Oral arsenic treatment for low-risk myelodysplastic syndromes

  This phase I test will see if a short-course oral arsenic regimen is safe and can help blood counts in adults with low-risk MDS who failed or are ineligible for ESAs or luspatercept.

  Recruiting at 3 sites Phase 1 Groupe Francophone des Myelodysplasies · Nice and 2 other locations · NCT06670222

• Treatment for patients with lower-risk myelodysplastic syndromes using R289

  This study is testing a new treatment called R289 to see if it can help people with lower-risk myelodysplastic syndromes who haven't responded well to other therapies.

  Recruiting at 13 sites Phase 1/2 Rigel Pharmaceuticals · Los Angeles, California and 12 other locations · NCT05308264

Quick answers

How many Low-risk Myelodysplastic Syndromes clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in France (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →